California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 18, 2026

Sep. 18, 2026

Summer Ends. Swim Training Doesn’t: Ear Pro and SwimOutlet Spotlight Year-Round Ear Protection

Indeterminate EIN Presswire

Sep. 18, 2026

From One Family’s Fight to $2.9 Million Raised: Team Parker for Life Brings San Diego Together for Childhood Cancer

Indeterminate EIN Presswire

Sep. 18, 2026

UCLA Brain-Gut Researcher, Emeran Mayer, MD, to Speak at Eudēmonia Summit

Indeterminate EIN Presswire

Sep. 18, 2026

IO Health Brings Real-Time AI Intelligence Directly Into Existing Home Health and Hospice EMR Workflows

Indeterminate EIN Presswire

Sep. 18, 2026

New Global Report Reveals Strong Pilates Demand - But Growing Pressure on the Profession

Indeterminate EIN Presswire

Sep. 18, 2026

California Communities Gain New Hope Through Align Recovery's Fentanyl Treatment

Indeterminate EIN Presswire

Sep. 18, 2026

Eromo Family's Illuminate Life Gala Returns to The Beverly Hilton October 15

Indeterminate EIN Presswire

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Johns Hopkins USFHP is One of the Highest-Rated Health Plans in the Nation

Indeterminate GlobeNewswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Indeterminate GlobeNewswire

Sep. 18, 2026

Pemi Named Best Perimenopause Supplement Brand of 2026

Indeterminate GlobeNewswire

Sep. 18, 2026

Elite Asia Group Unveils New Integrative Wellness Approach Combining Traditional Chinese Medicine and AI Technology

Indeterminate GlobeNewswire

Sep. 18, 2026

Why Implant Position Matters Long After Surgery: A Peoria Prosthodontic Perspective

Indeterminate GlobeNewswire